Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temsirolimus in Asian patients with advanced RCC
NCT00494091Phase 2Completed
- Sponsor
- Pfizer
- Start
- Feb 2007
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of temsirolimus in renal cell carcinoma (RCC), sponsored by Pfizer. Started Feb 2007; status: completed.
02
Drugs
temsirolimus
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00494091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00494091.